Critical review of the role of HTS in drug discovery.

'A wise use of lead discovery tactics will distinguish successful drug discovery engines.'

[1]  R. Spencer,et al.  High-throughput screening of historic collections: observations on file size, biological targets, and file diversity. , 1998, Biotechnology and bioengineering.

[2]  Ulf Bömer,et al.  High‐Throughput Screening for Kinase Inhibitors , 2005, Chembiochem : a European journal of chemical biology.

[3]  Christian Eggeling,et al.  Highly sensitive fluorescence detection technology currently available for HTS. , 2003, Drug discovery today.

[4]  Valler,et al.  Diversity screening versus focussed screening in drug discovery. , 2000, Drug discovery today.

[5]  Mark C. Fishman,et al.  Pharmaceuticals: A new grammar for drug discovery , 2005, Nature.

[6]  Mark S Butler,et al.  The role of natural product chemistry in drug discovery. , 2004, Journal of natural products.

[7]  Ricardo Macarron,et al.  Novel antibacterials: a genomics approach to drug discovery. , 2002, Current drug targets. Infectious disorders.

[8]  Marc Boillat,et al.  Precise nanoliter fluid handling system with integrated high-speed flow sensor. , 2005, Assay and drug development technologies.

[9]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[10]  S. Fox,et al.  High-Throughput Screening: Searching for Higher Productivity , 2004, Journal of biomolecular screening.

[11]  Paul B Taylor,et al.  A Standard Operating Procedure for Assessing Liquid Handler Performance in High-Throughput Screening , 2002, Journal of biomolecular screening.

[12]  G. Sitta Sittampalam,et al.  Design of Signal Windows in High Throughput Screening Assays for Drug Discovery , 1997 .

[13]  Phillip Gribbon,et al.  High-throughput drug discovery: what can we expect from HTS? , 2005, Drug discovery today.

[14]  Andrew M Davis,et al.  Components of successful lead generation. , 2005, Current topics in medicinal chemistry.

[15]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[16]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[17]  Sandra Fox,et al.  High Throughput Screening 2002: Moving Toward Increased Success Rates , 2002, Journal of biomolecular screening.